Marex Group’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-6,538
Closed -$358K 1027
2025
Q3
$358K Buy
6,538
+112
+2% +$5.6K ﹤0.01% 581
2025
Q2
$341K Sell
6,426
-1,579
-20% -$80.2K ﹤0.01% 428
2025
Q1
$347K Buy
8,005
+2,168
+37% +$110K 0.01% 423
2024
Q4
$328K Buy
5,837
+2,132
+58% +$133K 0.01% 433
2024
Q3
$252K Sell
3,705
-1,284
-26% -$72.5K 0.01% 419
2024
Q2
$211K Buy
+4,989
New +$275K 0.01% 498
2024
Q1
Sell
-3,971
Closed -$294K 568
2023
Q4
$294K Buy
+3,971
New +$260K 0.01% 393
2023
Q2
Sell
-3,679
Closed -$249K 263
2023
Q1
$249K Buy
+3,679
New +$236K 0.03% 217

Other funds holding EXAS

Marex Group's EXAS Position: Q4 2025 in Review

Marex Group sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 6,538 shares — an estimated $358K sold.

Marex Group first reported a position in EXAS in Q1 2023 and held it in 8 quarters. The position peaked at $358K in Q3 2025. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Marex Group reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • Marex Group sold 6,538 Exact Sciences shares in Q4 2025, an estimated $358K.
  • Marex Group first reported a position in Exact Sciences in Q1 2023 and held it in 8 quarters.
  • Marex Group's Exact Sciences position peaked at $358K in Q3 2025.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Marex Group's 13F filing for Q4 2025, filed 12 Feb 2026.